GenomEra Sepsis Products

GENOMERA
SEPSIS PRODUCTS
TM
FAST DNA DETECTION FOR
CRITICAL PATIENT CARE
Products not available in the USA.
TIME IS CRITICAL
FOR BLOODSTREAM INFECTIONS
When an infection has spread to the bloodstream, reliable results are needed fast.
GENOMERATM TESTS FOR RELIABLE DIAGNOSIS OF INFECTIONS
The immune response to bacteremia can cause sepsis and septic shock, which
result in a high rate of mortality despite intensive care. The current microbe identification methods may take from 1-2 days after receiving a positive signal from the
blood culture. It has been reported that each hour of delay in the administration of an
effective antimicrobial therapy results in a mean decrease of 8% in patient survival1.
Blood stream infectections
STAPHYLOCOCCUS AUREUS
MRSA
Staphylococcus aureus bacteremia is associated with
significant morbidity. S. aureus is the second-most
common pathogen causing blood stream infections
(BSI) worldwide and is the leading cause of nosocomial
BSIs in Europe2. The documented mortality rates of
S. aureus BSI’s is 20-40% 3.
MRSA (methicillin resistant Staphylococcus aureus) is a
bacteria resistant to a number of widely used antibiotics.
Accordingly, in bloodstream infections it is estimated five
times more lethal than the susceptible
S. aureus strains. Although MRSA strains are not more
aggressive or infectious than other strains of S. aureus,
the infections caused by it are much more difficult to
treat because many antibiotics will not work.
S. aureus
100
99,8
MRSA
100
99,8
Blood culture
• Easy to use molecular diagnosis
in 50 minutes
• High performance results
without excessive costs
GBS
Streptococcus
agalactiae
MRSA
S. aureus
SP
Streptococcus
pneumoniae
• No molecular diagnostic
knowledge needed
ACCURATE RESULTS IN 50 MINUTES WITH GENOMERATM CDX
STREPTOCOCCUS PNEUMONIAE
Mix the sample with buffer.
Pipette 35 µl into test chip.
Start the GenomEra CDX
assay run.
1) Kumar A et al. Crit Care Med 2006;34:1589-1596
2) Luzzaro F, Vigano EF, Fossati D, et al. Prevalence and drug susceptibility of pathogens causing bloodstream
infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis 2002;21:849-55.
3) Gould IM. MRSA bacteraemia. Int J Antimicrob Agents 2007;30(Suppl 1):66-70.
Streptococcus pneumoniae (S. pneumoniae) is the leading cause of invasive bacterial disease in children and in
the elderly populations. It is the most common bacterial pathogen in infants aged 1-3 months. The strong
tendency of S. pneumoniae to autolysis often makes
subculture and conventional confirmation
methods impossible.
STREPTOCOCCUS AGALACTIAE
While the rates of serious Streptococcus group B infections are much higher among newborns than among
any other age group, infections will occur in all age
groups and can be fatal. On average, 8% of adults with
invasive Streptococcus agalactiae infections will die.
S. agalactiae (GBS)
S. pneumonia
100
100
100
100
GENOMERATM INFECTION DIAGNOSTICS
Ordering Information
GenomEra MRSA/SA Blood Culture CDX-30-03-02, CDX-30-03-40
GenomEra GBS CDX-60-01-20, CDX-60-01-40
GenomEra S. pneumoniae CDX-70-01-20, CDX-70-01-40
GenomEra CDX System CDX-10-020
The Abacus Genomera CDX system consists
of ready-to-use tests, automated analyzer and
easy-to-use software.
ABACUS DIAGNOSTICA –
FOR RAPID AND EASY DNA TESTING
Abacus Diagnostica Oy, located in the
Science Park of Turku, Finland, develops and
manufactures rapid and simple solutions for
high perform-ance IVD DNA detection.
The company's proprietary, fully automated
testing platform GenomEra CDX takes DNA
testing to a new level of convenience and
simplicity.
The company’s IVD product portfolio enables
performing high-performance genetic testing
even outside a specialized laboratory environment and by personnel without experience in
molecular biology.
Abacus Diagnostica Tykistökatu 4 D, Electrocity FI-20520 Turku, FINLAND
Tel. +358 (0)20 7188 380 Fax +358 (0)20 7188 381
E-mail [email protected]
www.abacusdiagnostica.com
GenomEraTM and GenomEra CDXTM are trademarks of Abacus Diagnostica Oy
BSI v. 1.0, Feb 2014